NCT07247591

Brief Summary

The aim of this study is to define the starting and ending points of the adductor canal in adductor canal block (ACB) applications through distance measurements relative to the anterior superior iliac spine (ASIS) and the adductor tubercle. These measurements are performed using ultrasound (USG) and correlated with cadaveric data. Key research questions addressed include:

  • Can the start and end points of the adductor canal be formulated along a line drawn between the ASIS and the adductor tubercle?
  • Is there a definable relationship between the block application site and anatomical landmarks such as the vastoadductor membrane (VAM), the apex of the femoral triangle, and other adjacent structures that facilitates localization? By validating ultrasound measurements with cadaveric findings, the study aims to provide researchers with a more predictable and reliable method for determining the optimal site for adductor canal block administration.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 25, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

November 25, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

1 month

First QC Date

September 20, 2025

Last Update Submit

November 22, 2025

Conditions

Keywords

ASISADDUCTOR CANALBLOCK

Outcome Measures

Primary Outcomes (1)

  • location of the adductor canal

    Determine the location of the adductor canal on an imaginary line drawn between the anterior superior iliac spine and the adductor tubercle..

    Perioperative/Periprocedural

Secondary Outcomes (4)

  • Determining the entry point for adductor canal block

    Perioperative/Periprocedural

  • Adductor Canal neighborhoods

    Perioperative/Periprocedural

  • cadaver dissection

    Perioperative/Periprocedural

  • adductor canal

    Perioperative/Periprocedural

Study Arms (2)

ULTRASONOGRAPHIC PARTICIPANT GROUP

Participants will have ultrasound imaging of the adductor canal anatomy.

Cadaver Group

Anatomical measurements and adjacencies of the adductor canal will be examined on cadavers.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

He study at Etlik City Hospital will include patients who meet the following criteria: ASA classification of 1, 2, or 3, indicating individuals who are healthy or have mild to moderate systemic disease without major functional limitation; a BMI below 35 to exclude participants with obesity-related comorbidities; and an age range of 18 to 65 to ensure a broad yet controlled sample while avoiding age-related confounding factors. All participants must also provide informed consent, confirming their understanding of the study's purpose, procedures, and potential risks.

You may qualify if:

  • ASA 1-2-3 patients
  • BMI \<35
  • Ages 18-65
  • Those willing to participate in the study

You may not qualify if:

  • Those unwilling to participate in the study
  • Pregnant women
  • BMI \>35
  • ASA 4-5-6 patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Turkey (Türkiye)

Location

Study Officials

  • Müge Çakırca, Associate Professor

    Ankara Etlik City Hospital

    STUDY DIRECTOR

Central Study Contacts

Yasin USTA, M.D.

CONTACT

Müge Çakırca, Ass Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 20, 2025

First Posted

November 25, 2025

Study Start

November 25, 2025

Primary Completion

December 30, 2025

Study Completion

February 1, 2026

Last Updated

November 25, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations